Microglia morphology and proinflammatory signaling in the nucleus accumbens during nicotine withdrawal

Author:

Adeluyi Adewale1ORCID,Guerin Lindsey1,Fisher Miranda L.12ORCID,Galloway Ashley3ORCID,Cole Robert D.34,Chan Sherine S. L.56,Wyatt Michael D.1ORCID,Davis Shannon W.7ORCID,Freeman Linnea R.8ORCID,Ortinski Pavel I.34,Turner Jill R.12ORCID

Affiliation:

1. Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, USA.

2. Department of Pharmaceutical Sciences, University of Kentucky College of Pharmacy, Lexington, KY, USA.

3. Department of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA.

4. Department of Neuroscience, University of Kentucky School of Medicine, Lexington, KY, USA.

5. Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, USA.

6. Neuroene Therapeutics, Mt Pleasant, SC, USA.

7. Department of Biology, Furman University, Greenville, SC, USA.

8. Department of Biological Sciences, University of South Carolina, Columbia, SC, USA.

Abstract

Nearly 80% of smokers attempting to quit fail, but research on microglia may open a new avenue for smoking cessation drugs.

Funder

National Institutes of Health

PhRMA Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference67 articles.

1. Tobacco smoking: The leading cause of preventable disease worldwide;Samet J. M.;Thorac. Surg. Clin.,2013

2. The detox strategy in smoking comprising nutraceutical formulas of non-hydrolyzed carnosine or carcinine used to protect human health;Babizhayev M. A.;Hum. Exp. Toxicol.,2013

3. Treatment of nicotine addiction: Present therapeutic options and pipeline developments;Polosa R.;Trends Pharmacol. Sci.,2011

4. World Health Organization WHO Global Report: Mortality Attributable to Tobacco. Geneva Switzerland (2012); http://apps.who.int/iris/bitstream/10665/44815/1/9789241564434_eng.pdf.

5. Varenicline: An α4β2 nicotinic receptor partial agonist for smoking cessation;Coe J. W.;J. Med. Chem.,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3